XML 32 R22.htm IDEA: XBRL DOCUMENT v3.25.1
STOCKHOLDERS’ EQUITY (Tables)
3 Months Ended
Mar. 31, 2025
Equity [Abstract]  
SCHEDULE OF SHARE-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS

The fair value of each stock option granted during the three months ended March 31, 2024 was estimated using the Black-Scholes assumptions and or factors as follows:

 

Exercise price  $ 11.76-$70.00 
Expected dividend yield   0%
Risk free interest rate   4.01%-4.25%
Expected life in years   10 
Expected volatility   213-215%
SCHEDULE OF SHARE-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY

The following is an analysis of the stock option grant activity under the Plan:

 

   Number  

Weighted

Average

Exercise Price

  

Weighted

Average

Remaining Life

 
Stock Options               
Outstanding December 31, 2024   139,577   $5.29    5.77 
Granted   -    -    - 
Expired   (3,394)   69.98    - 
Exercised   -    -    - 
Outstanding March 31, 2025   136,183   $3.72    5.53 
SCHEDULE OF SHARE-BASED COMPENSATION NONVESTED SHARES

A summary of the status of the Company’s nonvested options as of March 31, 2025, and changes during the three months ended March 31, 2025 is presented below:

 

Nonvested Options  Options  

Weighted-

Average

Exercise Price

 
Nonvested at December 31, 2024   39,917   $26.46 
Granted   -    - 
Vested   (4,794)   1.07 
Forfeited   -    - 
Nonvested at March 31, 2025   35,123   $3.72 
SUMMARY OF WARRANT

A summary of warrant issuances are as follows:

 

   Number  

Weighted

Average

Exercise Price

  

Weighted

Average

Remaining Life

 
Warrants               
                
Outstanding December 31, 2024   354,904   $58.97    2.92 
Granted   -    -    - 
Expired   -    -    - 
Exercised   -    -    - 
Outstanding March 31, 2025   354,904   $58.97    2.67